Home › NDC Lookup › RxCUI directory › RxCUI 197929

Meprobamate 400 MG Oral Tablet — RxCUI 197929

RxNorm drug concept · Semantic clinical drug
RxCUI 197929 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197929
Official nameMeprobamate 400 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped12
Reported Medicaid activity (SDUD)23 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meprobamate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meprobamate is prescribed to manage anxiety disorders or to give short-term relief from anxiety symptoms. It's not meant for the everyday stress most people feel — it's for anxiety...
  • Yes, and this is one of the most important things to know about this medication. Meprobamate can cause both physical and psychological dependence, especially if you take more than...
  • No — you should avoid alcohol while taking meprobamate. Alcohol and meprobamate both slow down your central nervous system, and together the effects add up in ways that can be unpr...
  • Is it safe to drink alcohol while taking meprobamate?
📖 Read our full Meprobamate guide →

🕸️ Concept Web — How Meprobamate 400 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Meprobamate 400 MG Oral Tablet RxCUI 197929

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Meprobamate 6760
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meprobamate Oral Tablet 372775
    • Meprobamate Oral Product 1160979
    • Meprobamate Pill 1160980
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Meprobamate 400 MG 316244

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Meprobamate 400 MG SCDC · 316244
  • Meprobamate Oral Tablet SCDF · 372775
  • Meprobamate Oral Product SCDG · 1160979
  • Meprobamate Pill SCDG · 1160980

📦 FDA Products & Package NDCs

4 products · 12 package NDCs
12 package NDCs map to RxCUI 197929 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
46708-0019-30 30 TABLET in 1 BOTTLE (46708-019-30) MEPROBAMATE Alembic Pharmaceuticals Limited 2013-07-23
46708-0019-71 100 TABLET in 1 BOTTLE (46708-019-71) MEPROBAMATE Alembic Pharmaceuticals Limited 2013-07-23
46708-0019-91 1000 TABLET in 1 BOTTLE (46708-019-91) MEPROBAMATE Alembic Pharmaceuticals Limited 2013-07-23
46708-0020-30 30 TABLET in 1 BOTTLE (46708-020-30) MEPROBAMATE Alembic Pharmaceuticals Limited 2013-07-23
46708-0020-71 100 TABLET in 1 BOTTLE (46708-020-71) MEPROBAMATE Alembic Pharmaceuticals Limited 2013-07-23
46708-0020-91 1000 TABLET in 1 BOTTLE (46708-020-91) MEPROBAMATE Alembic Pharmaceuticals Limited 2013-07-23
62332-0019-30 30 TABLET in 1 BOTTLE (62332-019-30) Meprobamate Alembic Pharmaceuticals Inc. 2016-03-31
62332-0019-31 100 TABLET in 1 BOTTLE (62332-019-31) Meprobamate Alembic Pharmaceuticals Inc. 2016-03-31
62332-0019-91 1000 TABLET in 1 BOTTLE (62332-019-91) Meprobamate Alembic Pharmaceuticals Inc. 2016-03-31
62332-0020-30 30 TABLET in 1 BOTTLE (62332-020-30) Meprobamate Alembic Pharmaceuticals Inc. 2016-03-31
62332-0020-31 100 TABLET in 1 BOTTLE (62332-020-31) Meprobamate Alembic Pharmaceuticals Inc. 2016-03-31
62332-0020-91 1000 TABLET in 1 BOTTLE (62332-020-91) Meprobamate Alembic Pharmaceuticals Inc. 2016-03-31
Observed labelers: Alembic Pharmaceuticals Inc. (6) · Alembic Pharmaceuticals Limited (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.